Finding a good book to read on holiday may sometimes be a challenge. Luckily, the Open Pharma team is here to help with its shortlist of the best reads for summer 2019!
Blog
Weekly digest: what’s happening in open science?
Featuring a patient’s perspective on the Health Research Authority’s transparency consultation, the launch of the Journal of Trial and Error and the call for ResearchGate to educate users on responsible content sharing.
Weekly digest: what’s happening in open science?
Featuring the use of ‘spin’ in clinical trial abstracts, the first publication in UCL Open: Environment, a new clinical trial educational resource and insights from the OASPA webinar on learned societies and open access.
Open science is essential for medical research, says ABPI
The Association of the British Pharmaceutical Industry (ABPI) has said that it wants to take transparency to the next level, and has committed to making clinical research more accessible and understandable across the pharmaceutical industry.
Weekly digest: what’s happening in open science?
Featuring the release of the AMWA-EMWA-ISMPP position statement on predatory publishing, the hidden disclosures of medical journal editors, the citation advantage of preprints and the launch of the Open Pharma Calendar of Open Access Events
Weekly digest: what’s happening in open science?
Featuring the lack of transparency across clinical trials in French hospitals, the introduction of Registered Reports, the data detective who protects patients and one patient advocate’s experience with the medical publishing process
The latest scoop from Evidence-Based Medicine Live
Evidence is essential for identifying treatment priorities and developing polices, said Claire Allen of Evidence Aid, at Evidence-Based Medicine Live (EBMLive), which took place on 15–17 July in Oxford, UK.
Resolving conflicts of interest in medicine
At a workshop on managing conflicts of interest in medicine, Chris Winchester, CEO of Oxford PharmaGenesis and co-founder of Open Pharma, argued for openness.
Weekly digest: what’s happening in open science?
Featuring a summary of the Open Pharma team’s trip to Evidence-Based Medicine Live 2019, the potential use of Literature Programming to improve research transparency, a new data depot project in India and the lack of institutional incentives for researchers to publish open access
Research discoverability – insights from the OAI 11 CERN-UNIGE Workshop on Innovations in Scholarly Communication
When it comes to driving change in academic publishing practices, much of the focus is on making research outputs freely available to all those who wish to access them. However, open access publishing is just the tip of the iceberg.